Titan Pharmaceuticals Inc

Ownership Transactions Reported by 16 Insiders

Symbol
TTNP on Nasdaq, TTNPW on OTC
Industry
Biological Products, (No Diagnostic Substances)
Location
400 Oyster Point Blvd, Suite 505, San Francisco, California

There are no Buy or Sell transactions made by insiders since 7/16/2023

Titan Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Sire Group Ltd. 10%+ Owner $25.6 M Sep 13, 2023
Choon Choong 10%+ Owner $4.68 M Mar 18, 2024
David E. Lazar Chief Executive Officer, Director $123 K Jul 26, 2023
Eric Greenberg Director $81.5 K Oct 25, 2023
Avraham Ben-Tzvi Director $81.5 K Oct 25, 2023
David Natan Director $81.5 K Oct 25, 2023
Matthew C. McMurdo Director $81.5 K Oct 25, 2023
Katherine Beebe President and COO, Director $81.5 K Oct 25, 2023
James R. Mcnab Director $64.8 K Jan 28, 2022
Peter L. Chasey Director $61.5 K Jul 26, 2023
Francisco Flores Director $0 Apr 2, 2024
Firdauz Mokhtar Director $0 Apr 2, 2024
Marc Rubin Executive Chairman, Director Jan 5, 2022
Joseph A. Akers Director Jan 5, 2022
Brynner Chiam Director Oct 12, 2023
M. David Macfarlane Director Jan 5, 2022

Recent Insider Transactions by Companies or Individuals for Titan Pharmaceuticals Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership